Shanghai Xinhua Hospital gene‑editing trial kills six‑year‑old girl
A six‑year‑old Chinese girl, identified by the pseudonym Mei, died a week after receiving an experimental in‑vivo base‑editing therapy targeting her brain at Shanghai Xinhua Hospital. The treatment used trillions of adeno‑associated virus (AAV) vectors to deliver a customized gene‑editing system. Her parents paid about US$860,000 to fund the therapy and say they were not warned of fatal risks. The hospital’s ethics board concluded the death was definitely related to the treatment, attributing it to a microangiopathic thrombosis linked to the high‑dose viral vector. Shanghai Jiaotong University School of Medicine has set up a working group to conduct a comprehensive investigation, while the case was omitted from a Nature paper and the hospital received only minor administrative penalties with no public disciplinary action. The incident has revived international concerns over research ethics, informed consent, and regulatory oversight in China’s rapidly expanding biomedical sector, especially in the wake of the 2018 He Jiankui scandal.
Entities: Mei (pseudonym) · Nature journal · Qiu Zilong · Science magazine · Shanghai Jiaotong University School of Medicine · Shanghai Xinhua Hospital · Unnamed six‑year‑old Chinese patient
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 11 SOURCES] The case was omitted from a Nature paper published by the research team. (All belongs‑true articles)
- [● 11 SOURCES] The parents paid US$860,000 to fund the development of the gene‑editing treatment. (All belongs‑true articles)
- [● 11 SOURCES] Shanghai Jiaotong University School of Medicine established a working group to investigate the trial. (All belongs‑true articles)
- [● 3 SOURCES] The incident raised concerns about research ethics, informed consent, and regulatory oversight in China’s biomedical sector.
- [● 11 SOURCES] Researchers injected trillions of viral vectors carrying a customized gene‑editing system into the girl’s cerebrospinal fluid. (All belongs‑true articles)
- [● 11 SOURCES] The hospital’s ethics board concluded the death was definitely related to the treatment. (All belongs‑true articles)
- [● 11 SOURCES] The hospital received only minor administrative penalties and no public disciplinary action against the lead researcher. (All belongs‑true articles)
- [● 11 SOURCES] A six‑year‑old Chinese girl died after receiving an experimental in‑vivo base‑editing therapy. (All belongs‑true articles)
- [● 11 SOURCES] The death was attributed to microangiopathic thrombosis linked to the high‑dose AAV viral vector delivery. (All belongs‑true articles)